And this Sanofi-Maze-FTC episode might be, low-key, the story of the year
PBM Reform Gets Past the House. But Does That Matter?
And ICER continues to conduct its fatally flawed UPI report
And I'm still whining about the CMS "patient-focused listening sessions"
Plus some numbers to put some of the latest PBM "transparency" offerings in context
Plus more thinking about the new CVS "cost-plus" approach
And congrats to John Crowley!
And Biden is going to go all-in on drug-price proposals. Buckle up.
And it's World AIDS Day today
And the battle against copay accumulators appears to be far from over
Plus some datapoints on launch prices
Plus learning from the Thanksgiving table
